Skip to content

AbbVie ABBV Common Stock

Common Stock at other companies

Eli Lilly logo
Eli LillyLLY
$590M-0.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.12B
Amgen logo
AmgenAMGN
2.8B0.0%
Incyte logo
IncyteINCY
400M0.0%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$10.54B+0.3%
McKesson logo
McKessonMCK
800M0.0%

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$453.92B+34.7%
P/E124.9×+35.3×
P/S7.2×+1.4×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValueOutstanding.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's common stock?
AbbVie (ABBV) reported common stock of $18M in Q1 2026.
How has AbbVie's common stock changed year-over-year?
AbbVie's common stock decreased by 0.0% year-over-year, from $18M to $18M.
What is the long-term trend for AbbVie's common stock?
Over 5 years (2020 to 2025), AbbVie's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $18M to $18M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).